Literature DB >> 33529590

Prediction of Visual Field Progression from OCT Structural Measures in Moderate to Advanced Glaucoma.

Kouros Nouri-Mahdavi1, Vahid Mohammadzadeh2, Alessandro Rabiolo3, Kiumars Edalati2, Joseph Caprioli2, Siamak Yousefi4.   

Abstract

PURPOSE: To test the hypothesis that visual field (VF) progression can be predicted from baseline and longitudinal optical coherence tomography (OCT) structural measurements.
DESIGN: Prospective cohort study.
METHODS: A total of 104 eyes (104 patients) with ≥3 years of follow-up and ≥5 VF examinations were enrolled. We defined VF progression based on pointwise linear regression on 24-2 VF (≥3 locations with slope less than or equal to -1.0 dB/year and P < .01). We used elastic net logistic regression (ENR) and machine learning to predict VF progression with demographics, baseline circumpapillary retinal nerve fiber layer (RNFL), macular ganglion cell/inner plexiform layer (GCIPL) thickness, and RNFL and GCIPL change rates at central 24 superpixels and 3 eccentricities, 3.4°, 5.5°, and 6.8°, from fovea and hemimaculas. Areas-under-ROC curves (AUC) were used to compare models.
RESULTS: Average ± SD follow-up and VF examinations were 4.5 ± 0.9 years and 8.7 ± 1.6, respectively. VF progression was detected in 23 eyes (22%). ENR selected rates of change of superotemporal RNFL sector and GCIPL change rates in 5 central superpixels and at 3.4° and 5.6° eccentricities as the best predictor subset (AUC = 0.79 ± 0.12). Best machine learning predictors consisted of baseline superior hemimacular GCIPL thickness and GCIPL change rates at 3.4° eccentricity and 3 central superpixels (AUC = 0.81 ± 0.10). Models using GCIPL-only structural variables performed better than RNFL-only models.
CONCLUSIONS: VF progression can be predicted with clinically relevant accuracy from baseline and longitudinal structural data. Further refinement of proposed models would assist clinicians with timely prediction of functional glaucoma progression and clinical decision making.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33529590      PMCID: PMC8580576          DOI: 10.1016/j.ajo.2021.01.023

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.488


  43 in total

1.  Glaucoma progression detection using structural retinal nerve fiber layer measurements and functional visual field points.

Authors:  Siamak Yousefi; Michael H Goldbaum; Madhusudhanan Balasubramanian; Tzyy-Ping Jung; Robert N Weinreb; Felipe A Medeiros; Linda M Zangwill; Jeffrey M Liebmann; Christopher A Girkin; Christopher Bowd
Journal:  IEEE Trans Biomed Eng       Date:  2014-04       Impact factor: 4.538

2.  Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods.

Authors:  Kouros Nouri-Mahdavi; Joseph Caprioli; Anne L Coleman; Douglas Hoffman; Douglas Gaasterland
Journal:  Arch Ophthalmol       Date:  2005-02

3.  Applying "Lasso" Regression to Predict Future Visual Field Progression in Glaucoma Patients.

Authors:  Yuri Fujino; Hiroshi Murata; Chihiro Mayama; Ryo Asaoka
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

4.  Recognizing patterns of visual field loss using unsupervised machine learning.

Authors:  Siamak Yousefi; Michael H Goldbaum; Linda M Zangwill; Felipe A Medeiros; Christopher Bowd
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-03-21

5.  Can Glaucomatous Visual Field Progression be Predicted by Structural and Functional Measures?

Authors:  Wolfgang A Schrems; Laura-M Schrems-Hoesl; Christian Y Mardin; Robert Laemmer; Friedrich E Kruse; Folkert K Horn
Journal:  J Glaucoma       Date:  2017-04       Impact factor: 2.503

6.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

7.  Evaluating objective and subjective quantitative parameters at the initial visit to predict future glaucomatous visual field progression.

Authors:  Allison K Ungar; Gadi Wollstein; Hiroshi Ishikawa; Lindsey S Folio; Yun Ling; Richard A Bilonick; Robert J Noecker; Juan Xu; Larry Kagemann; Cynthia Mattox; Joel S Schuman
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2012-05-31

8.  Estimating Optical Coherence Tomography Structural Measurement Floors to Improve Detection of Progression in Advanced Glaucoma.

Authors:  Christopher Bowd; Linda M Zangwill; Robert N Weinreb; Felipe A Medeiros; Akram Belghith
Journal:  Am J Ophthalmol       Date:  2016-11-30       Impact factor: 5.258

9.  Defining 10-2 visual field progression criteria: exploratory and confirmatory factor analysis using pointwise linear regression.

Authors:  Carlos Gustavo de Moraes; Christian Song; Jeffrey M Liebmann; Joseph L Simonson; Rafael L Furlanetto; Robert Ritch
Journal:  Ophthalmology       Date:  2013-11-28       Impact factor: 12.079

10.  Systematic identification of feature combinations for predicting drug response with Bayesian multi-view multi-task linear regression.

Authors:  Muhammad Ammad-Ud-Din; Suleiman A Khan; Krister Wennerberg; Tero Aittokallio
Journal:  Bioinformatics       Date:  2017-07-15       Impact factor: 6.937

View more
  3 in total

1.  Macular Optical Coherence Tomography Imaging in Glaucoma.

Authors:  Alireza Kamalipour; Sasan Moghimi
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

2.  Combining Structural and Vascular Parameters to Discriminate Among Glaucoma Patients, Glaucoma Suspects, and Healthy Subjects.

Authors:  Alessandro Rabiolo; Federico Fantaguzzi; Riccardo Sacconi; Francesco Gelormini; Enrico Borrelli; Giacinto Triolo; Paolo Bettin; Andrew I McNaught; Joseph Caprioli; Giuseppe Querques; Francesco Bandello
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

3.  Multivariate Longitudinal Modeling of Macular Ganglion Cell Complex: Spatiotemporal Correlations and Patterns of Longitudinal Change.

Authors:  Vahid Mohammadzadeh; Erica Su; Lynn Shi; Anne L Coleman; Simon K Law; Joseph Caprioli; Robert E Weiss; Kouros Nouri-Mahdavi
Journal:  Ophthalmol Sci       Date:  2022-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.